Sterling Capital Management LLC Bio N Tech Se Transaction History
Sterling Capital Management LLC
- $7.74 Trillion
- Q3 2024
A detailed history of Sterling Capital Management LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Sterling Capital Management LLC holds 135 shares of BNTX stock, worth $15,049. This represents 0.0% of its overall portfolio holdings.
Number of Shares
135Holding current value
$15,049% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BNTX
# of Institutions
333Shares Held
39MCall Options Held
988KPut Options Held
1.69M-
Baillie Gifford & CO8.31MShares$926 Million0.75% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$504 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$486 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$211 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$201 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...